| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,525 |
37,163 |
$2.36M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
17,532 |
16,601 |
$619K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,300 |
6,291 |
$441K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,453 |
5,444 |
$399K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,808 |
4,798 |
$343K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,038 |
14,789 |
$322K |
| 99188 |
|
11,192 |
11,175 |
$299K |
| 87428 |
|
4,207 |
4,066 |
$262K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,362 |
3,335 |
$235K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
20,216 |
19,960 |
$205K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
10,072 |
9,386 |
$130K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,744 |
2,564 |
$96K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,298 |
1,292 |
$84K |
| 90461 |
|
7,224 |
7,173 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,071 |
956 |
$54K |
| 96127 |
|
5,196 |
5,138 |
$47K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
508 |
494 |
$46K |
| 87634 |
|
288 |
279 |
$18K |
| 99381 |
|
153 |
153 |
$13K |
| 99050 |
|
653 |
613 |
$10K |
| 87400 |
|
579 |
551 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
393 |
309 |
$5K |
| 81002 |
|
1,440 |
1,347 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
237 |
235 |
$3K |
| 81025 |
|
427 |
409 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
35 |
35 |
$3K |
| 90715 |
|
1,677 |
1,676 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
35 |
33 |
$2K |
| 99383 |
|
24 |
24 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 17110 |
|
12 |
12 |
$986.37 |
| 90686 |
|
2,411 |
2,402 |
$915.64 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
37 |
37 |
$756.65 |
| 90670 |
|
2,310 |
2,298 |
$544.00 |
| 90651 |
|
2,143 |
2,134 |
$500.34 |
| 80305 |
|
28 |
28 |
$249.76 |
| V5008 |
Hearing screening |
700 |
700 |
$141.76 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
15 |
15 |
$107.70 |
| 90674 |
|
466 |
465 |
$98.69 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
224 |
164 |
$92.27 |
| 90688 |
|
203 |
203 |
$77.68 |
| 90660 |
|
491 |
489 |
$66.96 |
| 90672 |
|
269 |
268 |
$25.20 |
| 90648 |
|
1,959 |
1,955 |
$14.00 |
| 99177 |
|
1,034 |
1,032 |
$12.00 |
| 90680 |
|
1,848 |
1,832 |
$11.00 |
| 90677 |
|
334 |
334 |
$9.00 |
| 90633 |
|
2,828 |
2,819 |
$5.00 |
| 90700 |
|
1,889 |
1,886 |
$4.00 |
| 90671 |
|
241 |
241 |
$4.00 |
| 90697 |
|
370 |
370 |
$3.00 |
| 90723 |
|
928 |
927 |
$3.00 |
| 90734 |
|
1,893 |
1,887 |
$2.50 |
| 90710 |
|
293 |
292 |
$1.50 |
| 90716 |
|
1,340 |
1,336 |
$1.50 |
| 90713 |
|
1,070 |
1,065 |
$1.00 |
| 90707 |
|
1,363 |
1,360 |
$0.50 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
164 |
162 |
$0.00 |
| 90685 |
|
89 |
86 |
$0.00 |
| 90744 |
|
234 |
231 |
$0.00 |
| 90698 |
|
349 |
345 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,539 |
1,531 |
$0.00 |
| 90696 |
|
102 |
102 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12 |
12 |
$0.00 |
| 90620 |
|
92 |
92 |
$0.00 |